ClearPoint Neuro, Inc.
US ˙ NasdaqCM ˙ US18507C1036

SecurityCLPT / ClearPoint Neuro, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Citadel Advisors Llc ownership in CLPT / ClearPoint Neuro, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 0 shares of ClearPoint Neuro, Inc. (US:CLPT) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 43,364 shares of ClearPoint Neuro, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (CLPT) in the form of stock options. The firm currently holds call options representing 58,500 of underlying shares valued at $532,350 USD and put options representing 42,000 of underlying shares valued at $382,200 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CLPT / ClearPoint Neuro, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CLEARPOINT NEURO COM 18507C103 0 -43,364 -100.00 0 -100.00
2026-02-17 2025-12-31 13F CLEARPOINT NEURO COM 18507C103 43,364 -43,128 -49.86 593 -68.52 0.0001
2025-11-14 2025-09-30 13F CLEARPOINT NEURO COM 18507C103 86,492 6,923 8.70 1,885 98.32 0.0003
2025-08-14 2025-06-30 13F CLEARPOINT NEURO COM 18507C103 79,569 67,360 551.72 950 555.17 0.0002
2025-05-15 2025-03-31 13F CLEARPOINT NEURO COM 18507C103 12,209 -12,969 -51.51 145 -62.53 0.0000
2025-02-14 2024-12-31 13F CLEARPOINT NEURO COM 18507C103 25,178 -60,736 -70.69 387 -59.81 0.0001
2024-11-14 2024-09-30 13F CLEARPOINT NEURO COM 18507C103 85,914 -99,078 -53.56 963 -3.41 0.0002
2024-08-14 2024-06-30 13F CLEARPOINT NEURO COM 18507C103 184,992 110,216 147.39 997 96.26 0.0002
2024-05-15 2024-03-31 13F CLEARPOINT NEURO COM 18507C103 74,776 46,759 166.90 508 167.37 0.0001
2024-02-14 2023-12-31 13F CLEARPOINT NEURO COM 18507C103 28,017 -58,191 -67.50 190 -55.92 0.0000
2023-11-14 2023-09-30 13F CLEARPOINT NEURO COM 18507C103 86,208 -17,706 -17.04 432 -42.69 0.0001
2023-08-14 2023-06-30 13F CLEARPOINT NEURO COM 18507C103 103,914 29,976 40.54 752 20.51 0.0002
2023-05-15 2023-03-31 13F CLEARPOINT NEURO COM 18507C103 73,938 -51,002 -40.82 624 -41.02 0.0001
2023-02-14 2022-12-31 13F CLEARPOINT NEURO COM 18507C103 124,940 98,165 366.63 1,058 281.95 0.0002
2022-11-14 2022-09-30 13F CLEARPOINT NEURO COM 18507C103 26,775 -8,342 -23.75 277 -39.52 0.0001
2022-08-15 2022-06-30 13F CLEARPOINT NEURO COM 18507C103 35,117 35,117 458 0.0001
2022-05-16 2022-03-31 13F CLEARPOINT NEURO COM 18507C103 0 -31,995 -100.00 0 -100.00
2022-02-14 2021-12-31 13F CLEARPOINT NEURO COM 18507C103 31,995 -10,233 -24.23 359 -52.13 0.0001
2021-11-15 2021-09-30 13F CLEARPOINT NEURO Cmn 18507C103 42,228 1,728 4.27 750 -2.98 0.0002
2021-08-16 2021-06-30 13F CLEARPOINT NEURO COM 18507C103 40,500 40,500 773 0.0002
2020-02-14 2019-12-31 13F MRI INTERVENTIONS Cmn 55347P209 0 -10,268 -100.00 0 -100.00
2019-11-14 2019-09-30 13F MRI INTERVENTIONS Cmn 55347P209 10,268 10,268 52 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CLEARPOINT NEURO COM Call 58,500 -48.59 532 -65.81 n/a n/a n/a
2026-02-17 2025-12-31 13F CLEARPOINT NEURO COM Call 113,800 13.91 1,557 -28.49 n/a n/a n/a
2025-11-14 2025-09-30 13F CLEARPOINT NEURO COM Call 99,900 345.98 2,177 714.98 n/a n/a n/a
2025-08-14 2025-06-30 13F CLEARPOINT NEURO COM Call 22,400 -57.17 267 -57.00 n/a n/a n/a
2025-05-15 2025-03-31 13F CLEARPOINT NEURO COM Call 52,300 -20.27 622 -38.39 n/a n/a n/a
2025-02-14 2024-12-31 13F CLEARPOINT NEURO COM Call 65,600 134.29 1,009 222.04 n/a n/a n/a
2024-11-14 2024-09-30 13F CLEARPOINT NEURO COM Call 28,000 35.27 314 181.98 n/a n/a n/a
2024-08-14 2024-06-30 13F CLEARPOINT NEURO COM Call 20,700 -8.41 112 -27.45 n/a n/a n/a
2024-05-15 2024-03-31 13F CLEARPOINT NEURO COM Call 22,600 -53.59 154 -53.64 n/a n/a n/a
2024-02-14 2023-12-31 13F CLEARPOINT NEURO COM Call 48,700 -18.43 331 10.37 n/a n/a n/a
2023-11-14 2023-09-30 13F CLEARPOINT NEURO COM Call 59,700 34.76 299 -6.56 n/a n/a n/a
2023-08-14 2023-06-30 13F CLEARPOINT NEURO COM Call 44,300 75.79 321 50.94 n/a n/a n/a
2023-05-15 2023-03-31 13F CLEARPOINT NEURO COM Call 25,200 30.57 213 30.06 n/a n/a n/a
2023-02-14 2022-12-31 13F CLEARPOINT NEURO COM Call 19,300 -66.90 163 -73.01 n/a n/a n/a
2022-11-14 2022-09-30 13F CLEARPOINT NEURO COM Call 58,300 -16.24 604 -33.48 n/a n/a n/a
2022-08-15 2022-06-30 13F CLEARPOINT NEURO COM Call 69,600 24.96 908 56.55 n/a n/a n/a
2022-05-16 2022-03-31 13F CLEARPOINT NEURO COM Call 55,700 -21.44 580 -27.14 n/a n/a n/a
2022-02-14 2021-12-31 13F CLEARPOINT NEURO COM Call 70,900 -23.60 796 -51.67 n/a n/a n/a
2021-11-15 2021-09-30 13F CLEARPOINT NEURO Cmn Call 92,800 37.69 1,647 27.97 n/a n/a n/a
2021-08-16 2021-06-30 13F CLEARPOINT NEURO COM Call 67,400 609.47 1,287 540.30 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CLEARPOINT NEURO COM Call 9,500 201 n/a n/a n/a
2021-05-17 2021-03-31 13F CLEARPOINT NEURO COM Call 9,500 201 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CLEARPOINT NEURO COM Put 42,000 -46.29 382 -64.27 n/a n/a n/a
2026-02-17 2025-12-31 13F CLEARPOINT NEURO COM Put 78,200 -6.68 1,070 -41.46 n/a n/a n/a
2025-11-14 2025-09-30 13F CLEARPOINT NEURO COM Put 83,800 132.78 1,826 325.64 n/a n/a n/a
2025-08-14 2025-06-30 13F CLEARPOINT NEURO COM Put 36,000 19.60 430 20.17 n/a n/a n/a
2025-05-15 2025-03-31 13F CLEARPOINT NEURO COM Put 30,100 76.02 358 36.26 n/a n/a n/a
2025-02-14 2024-12-31 13F CLEARPOINT NEURO COM Put 17,100 -34.48 263 -10.27 n/a n/a n/a
2024-11-14 2024-09-30 13F CLEARPOINT NEURO COM Put 26,100 667.65 293 1,522.22 n/a n/a n/a
2024-08-14 2024-06-30 13F CLEARPOINT NEURO COM Put 3,400 -34.62 18 -48.57 n/a n/a n/a
2024-05-15 2024-03-31 13F CLEARPOINT NEURO COM Put 5,200 147.62 35 150.00 n/a n/a n/a
2024-02-14 2023-12-31 13F CLEARPOINT NEURO COM Put 2,100 -53.33 14 -36.36 n/a n/a n/a
2023-11-14 2023-09-30 13F CLEARPOINT NEURO COM Put 4,500 -73.99 23 -82.40 n/a n/a n/a
2023-08-14 2023-06-30 13F CLEARPOINT NEURO COM Put 17,300 -44.90 125 -52.83 n/a n/a n/a
2023-05-15 2023-03-31 13F CLEARPOINT NEURO COM Put 31,400 -17.59 265 -17.70 n/a n/a n/a
2023-02-14 2022-12-31 13F CLEARPOINT NEURO COM Put 38,100 -71.88 323 -77.07 n/a n/a n/a
2022-11-14 2022-09-30 13F CLEARPOINT NEURO COM Put 135,500 797.35 1,404 612.69 n/a n/a n/a
2022-08-15 2022-06-30 13F CLEARPOINT NEURO COM Put 15,100 -12.21 197 10.06 n/a n/a n/a
2022-05-16 2022-03-31 13F CLEARPOINT NEURO COM Put 17,200 -66.67 179 -69.08 n/a n/a n/a
2022-02-14 2021-12-31 13F CLEARPOINT NEURO COM Put 51,600 -15.55 579 -46.64 n/a n/a n/a
2021-11-15 2021-09-30 13F CLEARPOINT NEURO Cmn Put 61,100 7.19 1,085 -0.28 n/a n/a n/a
2021-08-16 2021-06-30 13F CLEARPOINT NEURO COM Put 57,000 1,088 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.